Transparency data

UK NSC agenda November 2022

Updated 5 May 2023

© Crown copyright 2023

This publication is licensed under the terms of the Open 바카라 사이트 Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at /government/publications/uk-nsc-meeting-november-2022/uk-nsc-agenda-november-2022

1. Introduction and apologies

2. Call for new interests

3. Minutes of the last meeting

4. UK NSC expanded remit and adoption of the Chief Medical Officers바카라 사이트™ (°ä²Ñ°¿²õ바카라 사이트™) recommendations

4.1 Recommendation 5 바카라 사이트“ terms of reference for the creation of a feasibility assessment group

4.2 Recommendation 6b 바카라 사이트“ patient and public voice (PPV)

5. Matters arising 바카라 사이트“ Director바카라 사이트™s update

5.1 In-service evaluation on non-invasive prenatal testing (NIPT)

5.2 In-service evaluation on severe combined immunodeficiency (SCID)

5.3 Cervical screening intervals

5.4 Targeted lung cancer screening update

6. UK NSC website and blog analytics

7. Stakeholder activity update

8. Report on international consensus on informed choice

9. Fetal, maternal and child health (FMCH) screening

9.1 FMCH group minutes

9.2 Tyrosinaemia 바카라 사이트“ further modelling

9.3 Evidence summary 바카라 사이트“ screening for autism spectrum disorder

9.4 Evidence summary 바카라 사이트“ antenatal screening for the prevention and prediction of pre-eclampsia

9.5 Evidence map 바카라 사이트“ iron deficiency in children

9.6 Evidence map 바카라 사이트“ antenatal screening for Human T-cell lymphotropic virus (HTLV)

10. Adult screening

10.1 Adult reference group (ARG) minutes

11. Update on the research methodology group (RMG)

12. Any other business

Back to top